(Q44514035)

3 December 2017

A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit (English)

1 reference

3 December 2017

George M Palatianos

1

1 reference

3 December 2017

Christophoros N Foroulis

2

1 reference

3 December 2017

Maria I Vassili

3

1 reference

3 December 2017

George Astras

4

1 reference

3 December 2017

Konstantinos Triantafillou

5

1 reference

3 December 2017

Emmanuel Papadakis

6

1 reference

3 December 2017

Angela A Lidoriki

7

1 reference

3 December 2017

Eugenia Iliopoulou

8

1 reference

3 December 2017

Efthimia N Melissari

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

The Annals of Thoracic Surgery

3 December 2017

1 reference

3 December 2017

76

1 reference

3 December 2017

1

1 reference

3 December 2017

129-135

1 reference

Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

HEPARIN BONDING ON COLLOIDAL GRAPHITE SURFACES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Specific complement inhibition with heparin-coated extracorporeal circuits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Surface-bound heparin--panacea or peril?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European Working Group on heparin coated extracorporeal circulation circuits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparin coating with aprotinin reduces blood activation during coronary artery operations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Risk and benefit of low systemic heparinization during open heart operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Systemic inflammatory response syndrome after cardiac operations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

SIRS--the systemic inflammatory response syndrome after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900338-2

10.1016/S0003-4975(03)00338-2

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference